OOIR: Observatory of International Research

Papers

(The H4-Index of Vaccine is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Evidence for antibody as a protective correlate for COVID-19 vaccines	771
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	489
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	403
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	378
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	364
mRNA vaccines manufacturing: Challenges and bottlenecks	270
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey	265
Myocarditis following COVID-19 mRNA vaccination	210
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge	188
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine	184
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	176
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia	165
The disease burden of influenza beyond respiratory illness	156
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States	156
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis	146
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis	145
Individual preferences for COVID-19 vaccination in China	145
COVID-19 vaccine intentions in the United States, a social-ecological framework	139
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine	134
Towards a population-based threshold of protection for COVID-19 vaccines	130
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial	130
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study	128
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis	122
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018	121
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	120

Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions	119
Prenatal maternal COVID-19 vaccination and pregnancy outcomes	116
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization	113
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization	109
The demand for a COVID-19 vaccine in Ecuador	109
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	109
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia	107
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response	104
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis	104
Timing of COVID-19 vaccine approval and endorsement by public figures	102
Preferences for a COVID-19 vaccine in Australia	100
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches	97
Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-indu	94
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic	90
Christian nationalism and COVID-19 vaccine hesitancy and uptake	89
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia	88
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	85
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis	84
COVID-19 vaccine – Long term immune decline and breakthrough infections	82
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models	82
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis	81
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use	76
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis	76
Understanding immunosenescence and its impact on vaccination of older adults	75
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	74
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization	73
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake	73
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	72
The need for inclusion of pregnant women in COVID-19 vaccine trials	71
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis	71
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies	70
Global production capacity of seasonal and pandemic influenza vaccines in 2019	70
Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey	69
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil	69
Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries	68
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada	67
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates	67
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey	66
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement	66
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research	65